PA8464301A1 - Compuestos derivados del cromeno - Google Patents

Compuestos derivados del cromeno

Info

Publication number
PA8464301A1
PA8464301A1 PA19988464301A PA8464301A PA8464301A1 PA 8464301 A1 PA8464301 A1 PA 8464301A1 PA 19988464301 A PA19988464301 A PA 19988464301A PA 8464301 A PA8464301 A PA 8464301A PA 8464301 A1 PA8464301 A1 PA 8464301A1
Authority
PA
Panama
Prior art keywords
chrome
hydrogen
derived compounds
compounds
means hydrogen
Prior art date
Application number
PA19988464301A
Other languages
English (en)
Inventor
Rafael Foguet Ambros
Aurelio Sacristan Munoz
Joseph Ma Castello Barenys
Jose A Ortiz Hernandez
Jordi Bolos Gener
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of PA8464301A1 publication Critical patent/PA8464301A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

ESTA INVENCION CONSISTE EN COMPUESTOS DERIVADOS DEL CROMENO DE FORMULA (1): DONDE R SIGNIFICA HIDROGENO, CHO, CH2OR2 Ó COOH, R1 SIGNIFICA HIDROGENO Ó CH2OH, Y R2 SIGNIFICA ALQUILO CUYO NUMERO DE CARBONOS ESTA COMPRENDIDO ENTRE 1 Y 4, AMBOS INCLUSIVE, CON LA CONDICION DE QUE UN SUSTITUYENTE ELEGIDO ENTRE R Y R1 DEBE SER HIDROGENO, ASI COMO SUS SALES FARMACEUTICAMENTE ACEPTABLES. SE DESCRIBE TAMBIEN EL PROCEDIMIENTO PARA SU OBTENCION Y LAS COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN. ESTOS COMPUESTOS SON NUEVOS Y TIENEN APLICACION EN EL TRATAMIENTO DE LA PSICOSIS, LA ESQUIZOFRENIA Y LA ALERGIA.
PA19988464301A 1997-12-30 1998-12-10 Compuestos derivados del cromeno PA8464301A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009702718A ES2144355B1 (es) 1997-12-30 1997-12-30 Compuestos derivados del cromeno.

Publications (1)

Publication Number Publication Date
PA8464301A1 true PA8464301A1 (es) 2000-09-29

Family

ID=8301662

Family Applications (1)

Application Number Title Priority Date Filing Date
PA19988464301A PA8464301A1 (es) 1997-12-30 1998-12-10 Compuestos derivados del cromeno

Country Status (18)

Country Link
US (1) US6187793B1 (es)
EP (1) EP0970076A1 (es)
JP (1) JP2001515517A (es)
KR (1) KR20000075840A (es)
AR (1) AR017968A1 (es)
AU (1) AU2514399A (es)
BR (1) BR9807276A (es)
CA (1) CA2282596A1 (es)
ES (1) ES2144355B1 (es)
IL (1) IL131572A0 (es)
NO (1) NO994161L (es)
NZ (1) NZ337260A (es)
PA (1) PA8464301A1 (es)
PL (1) PL335463A1 (es)
RU (1) RU2179556C2 (es)
TW (1) TW464650B (es)
WO (1) WO1999035144A1 (es)
ZA (1) ZA9811217B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007051735A1 (en) 2005-11-03 2007-05-10 F. Hoffmann-La Roche Ag Arylsulfonylchromans as 5-ht6 inhibitors indolylmaleimide derivatives as protein kinase inhibitors
CN102206214B (zh) * 2011-04-07 2014-03-12 华中科技大学 苯并吡喃酮类衍生物及其应用
JP5608873B2 (ja) * 2011-05-18 2014-10-15 ラクオリア創薬株式会社 ４−｛［４−（｛［４−（２，２，２−トリフルオロエトキシ）−１，２−ベンズイソオキサゾール−３−イル］オキシ｝メチル）ピペリジン−１−イル］メチル｝−テトラヒドロ−２ｈ−ピラン−４−カルボン酸の多形形態
CN103694233B (zh) * 2013-12-10 2016-08-17 沈阳药科大学 苯并异噁唑类化合物及其应用
CN105153246B (zh) * 2015-08-05 2018-05-25 广州嘉德乐生化科技有限公司 一种蔗糖脂肪酸酯的制备方法及其乳饮料组合物
CN111320619A (zh) * 2018-12-17 2020-06-23 江苏恩华药业股份有限公司 一种类酰胺类衍生物的杂质及用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3117389A1 (de) * 1981-05-02 1982-11-18 Boehringer Mannheim Gmbh, 6800 Mannheim Benzopyranylether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
US4678787A (en) * 1985-01-30 1987-07-07 Warner-Lambert Company 4H-1-benzopyran-4-ones and their sulfur containing analogs
EP0235463A3 (en) * 1985-12-20 1990-01-17 A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) N-substituted-arylalkyl and arylalkylene piperidines as cardiovascular antihistaminic and antisecretory agents
DE69021645T2 (de) * 1989-05-19 1996-02-22 Hoechst-Roussel Pharmaceuticals Inc., Somerville, N.J. N-(aryloxyalkyl)heteroarylpiperidine und -heteroarylpiperazine, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente.
FR2654104B1 (fr) * 1989-11-07 1992-01-03 Adir Nouveaux derives du 1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
US5147881A (en) * 1990-11-14 1992-09-15 Pfizer Inc 4-(1,2-benzisoxazolyl)piperidine antipsychotic agents
JP3193508B2 (ja) * 1993-03-05 2001-07-30 興和株式会社 ピペリジン誘導体
ES2074966B1 (es) * 1994-02-11 1996-06-16 Vita Invest Sa Procedimiento para la obtencion de 3-(2-(4-(6-fluoro-benzo(d)isoxazol-3-il)piperidin-1-il)-etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido-(1,2-a)pirimidin-4-ona.
IL112764A0 (en) * 1994-03-18 1995-05-26 Ferrer Int New chromene derivatives
IL117646A (en) * 1995-04-12 2000-06-01 Ferrer Int 7-¬3-¬4-(6-fluoro-1,2-benzisoxazole-3-YL)piperidin-1-YL¾propoxy¾3-alkyl-chromen-4-ones their preparation their uses and pharmaceutical compositions comprising them

Also Published As

Publication number Publication date
ES2144355A1 (es) 2000-06-01
ES2144355B1 (es) 2001-01-01
US6187793B1 (en) 2001-02-13
CA2282596A1 (en) 1999-07-15
AR017968A1 (es) 2001-10-24
ZA9811217B (en) 1999-07-14
KR20000075840A (ko) 2000-12-26
RU2179556C2 (ru) 2002-02-20
JP2001515517A (ja) 2001-09-18
EP0970076A1 (en) 2000-01-12
NZ337260A (en) 2000-09-29
AU2514399A (en) 1999-07-26
NO994161L (no) 1999-10-25
TW464650B (en) 2001-11-21
WO1999035144A1 (en) 1999-07-15
IL131572A0 (en) 2001-01-28
PL335463A1 (en) 2000-04-25
NO994161D0 (no) 1999-08-27
BR9807276A (pt) 2000-05-02

Similar Documents

Publication Publication Date Title
AR013477A1 (es) Prostaglandinas de tetrahidro sustituido c16-20 aromatico utiles como agonistas de fp.
GT199900008A (es) Compuestos 4-(2-ceto-1-benzilimidazolinil) piperidina como agonistas del receptor orl1
ES2186015T3 (es) Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol.
AR038136A1 (es) Cicloalcanindoles con sustitucion con fluor composiciones que contienen estos compuestos y metodos de tratamiento
PA8583101A1 (es) Nuevos compuestos de isotiazol e isoxazol como inhibidores del factor de crecimiento transformador (tgf)
ES2183937T3 (es) Inhibidores de la adhesion celular.
GT199800158AA (es) Agonistas de prostaglandinas y su uso para tratar trastornos oseos
PA8452701A1 (es) Agonistas de prostaglandinas
SV1999000016A (es) Derivados de 2-(purin-9-il-tetrahidrofuran-3,4-diol ref. pg3443/sv
CU23241B7 (es) 2-fenil-1-(4(2-aminoetoxi)-benzil)-indol en combinacion con estrogenos
PA8480101A1 (es) Derivados de quinolin-2-ona alquinilsustituidos utiles como agentes anticancerosos
ES2134859T3 (es) Derivados de 4-carboxoamido-piperidina, productos intermedios y uso como antagonistas de neurokinina.
CO5160262A1 (es) Formulaciones farmaceuticas de liberacion controlada
ES2191320T3 (es) Derivados de piperazina y su uso como agentes anti-inflamatorios.
CR9507A (es) Sulfonamidas de diarisulfona y sus usos
UY26889A1 (es) Compuestos farmacéuticos
PA8465901A1 (es) Nuevos derivados de la eritromicina
ES2181766T3 (es) Analogos de delda 12,13-isotaxol, uso antineoplasico y composiciones farmaceuticas que los contienen.
ES2181153T3 (es) Compuestos de triazinilaminoestilbeno.
CR7678A (es) Heterociclilpyrimidinos sustituidos
ES2183332T3 (es) Aminoacidos biciclicos aromaticos.
GT199800106A (es) Azetidinas.
AR021843A1 (es) Derivados de propanolamina sustituidos con heterociclos, procedimiento para su preparacion, y su utilizacion.
MX9306311A (es) Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
PA8464301A1 (es) Compuestos derivados del cromeno